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Abstract
Human KC cell monolayer inoculated with concentraten Mason-Pfizer monkey virus (MPMV)
showed syncytia formation within an hour. The cell fusion was blocked by the treatment of the
MPMV with neutralizing antiserum. Treatment of the MPVM with beta-propiolactone resulted in
the loss of infectivity although KC cell fusion ability of the virus still remained. KC cells inoc-
ulated with unconcentrated MPMV showed no cell fusion even after several transfers, although a
chronic MPMV infection was established. The virus-producing KC cells were refractory to fusion
by MPMV. Human embryonic lung cells (HEL) were infected by serially diluted MPMV harvested
from virus-producing culture, transferred twice, then cultivated together with KC cells for syncy-
tia formation to examine the end point dilution titer of the virus. HEL infected by 10(-4)-diluted
MPMV still induced syncytia formation by cocultivation with KC cells.
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Abstract. Human KG cell monolayer inoculated with concentrated
Mason-Pfizer monkey virus (MPMVl showed syncytia formation with-
in an hour. The cell fusion was blocked by the treatment of the
MPMV with neutralizing antiserum. Treatment of the MPMV with
(S-propiolactone resulted in the loss of infectivity although KG cell
fusion ability of the virus still remained. KC cells inoculated with
unconcentrated MPMV showed no cell fusion even after several
transfers, although a chronic MPMV infection was established. The
virus-producing KC cells were refractory to fusion by MPMV. Hu-
man embryonic lung cells (HELl were infected by serially diluted
MPMV harvested from virus-producing culture, transferred twice, then
cultivated together with KC cells for syncytia formation to examine
the end point dilution titer of the virus. HEL infected by 1O-4-diluted
MPMV still induced syncytia formation by cocultivation with KG
cells.
Mason-Pfizer monkey virus (MPMV), a new type of RNA tumor virus, was
isolated from mammary cancer of monkey (1) and classified as D-type (Neither
B- nor C-type) reverse transcriptase virus (2). Recently, it has been shown that
MPMV induced cell fusion in KC cells (3,4), a human glioma cell line infected
with an avian sarcoma virus. Several RNA tumor viruses of various origins have
been reported as inducing cell fusion in rat XC and/or human KC cells (5). The
mechanism of cell fusion which results in syncytia formation is still unknown,
although in rat XC cell fusion by murine leukemia virus (MuLV), the fusion was
only from without, viral spikes playing an important role in the initiation of cell
fusion (6).
In this report we studied the characteristics of KC cell syncytia formation
by MPMV and tried to titrate the infectivity of MPMV using the KC cell fusion
phenomenon.
MATERIALS AND METHODS
Cells. The monkey mammary tumor cell line (GMMT, ~3328-28l; Pfizer
Inc., obtained from Dr. Gelderblom, Berlin) was derived from mammary tumor
cells of a rhesus monkey which had been cocultivated with normal rhesus
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embryo cells. The culture produces MPMV. The human KC cell line originally
named 118 MG-EM (7) was supplied by Dr. j. Ponten, Uppsala, Sweden. Hu-
man embryonic lung cells (HEL) were prepared by primary culture from hu-
man feta11ung. All cells were maintained in Eagle's minimal essential medium
(Du1becco's modification) supplemented with 10% heat-inactivated calf serum.
Antiserum. Goat antiserum against MPMV (~2S-761) from Pfizer Inc., ob-
tained from Dr. H. Bauer, Giessen, Germany, was previously shown to block
cell fusion by cocu1tivation of KC cells with MPMV-producing cells (8). Non-
immune goat serum was the control.
Concentration of MPMV. MPMV from CMMT culture supernatant was cen-
trifuged at 4,000 rpm for 20 min to remove cell debris and then the virus was
centrifuged in an SW 27 rotor at 25,000 rpm for 45 min on to 0.5 m1 of a 70%
sucrose cushion (6) or pelleted without sucrose,
KC cell fusion. As DEAE-dextran (Pharmacia, Sweden) enhanced XC cell
fussion by MuLV (6), this agent was also used for KC cell fusion by MPMV.
DEAE-dextran was added to the medium of the KC cell monolayer to a final
concentration of 25 ,ug/m1 for 30 min before they were subjected to the inocula-
tion of concentrated MPMV. The virus concentrate either on a sucrose cushion
or in culture medium after suspension of the pellet was added on to the mono-
layer KC cells for 10 min. Growth medium was added to the culture after
removal of the virus solution. For mixed culture syncytia formation study, both
trypsinized KC cells and trypsinized MPMV-producing cells were mixed (KC:
MPMV-producing cells=3: 1). After overnight cocu1tivation, the cultures were
fixed with 100% methanol, stained by Giemsa solution, and examined with the
light microscope.
Treatment of MPMV. Overnight treatment of concentrated MPMV with a
virus-inactivating drug, j3-propio1actone (Sigma), known to inactivate the in-
fectivity of Sendai virus (9) and MuLV (6) without affecting the fusion ability
of these viruses, was performed at a final concentration of 0.02%. Treatment
of MPMV with goat anti-MPMV serum or with non-immune goat serum was
performed at a final serum dilution of 20% for 60 min at 3rC.
Infect iv it.J. assay. As HEL was susceptible to MPMV, HEL was chosen as
the assay cells. Virus-containing culture supernatant of CMMT was serially
diluted with growth medium and each 0.2 m1 of them was added to DEAE-
dextran treated HEL in 6 em culture dishes. The cultures were incubated for
60 min, then 5 ml growth medium was added to the cultures which were then
kept in a CO2 incubator. They were transferred every 5 days. At every trans-
fer, a part of the cells was cocultivated with KC cells. One day after cocu1ti-
vation, the cultures were Giemsa stained and examined for the presence of KC
syncytia.
RESULTS
KG cell syncytia formation by concentrated MPMV. Forty-fold concentration
of MPMV by centrifugation on to a sucrose cushion induced KC cell syncytia
formation within an hour. The maximal syncytia formation was observed 4 hr
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after virus inoculation. When MPMV was pelleted without a sucrose cushion on
to the bottom of the centrifuge tube, then was added to KG monolayer cells, no
KG cell syncytia formation was observed. Treatment of the concentrated
MPl\1V with goat anti-MPMV serum blocked KG cell syncytia formation (Table
I and Fig. 2) while non-immune goat serum had no such effect (Table I and Fig.
I). Overnight treatment of MPMV with p-propiolactone still induced KG cell
TABLE 1. KC CELL SYNCYTIA FORMATION BY CONCENTRATED MPMV
------------ ~ ~-~-~-~---
Treatment
None
Nonimmune serum
a: MPMV serum
,3-propiolactone
Dilution
Fusion activity
+
+
+
Infectivity
+
+
+
Fig. 1 Fig. 2
Fig. 1. KC cell syncytia formation by MPMV. Concentrated MPMV was incubated
wi th nonimmune goat serum in a final dilution of 20% at 37°C for 60 min and then added on
to KC cell monolayer. The culture was fixed 3 hr after virus infection with methanol and
stained with Giemsa solution. Magnification x60.
Fig. 2. Syncytia formation block by neutralizing serum. Concentrated MPMV was in-
cubated with goat anti-MPMV serum in a final dilution of 20% at 3rc for 60 min and then
added on to KC cell monolayer. The culture was treated under the same conditions as de-
scribed in the legend to Fig. 1. Magnification x 60.
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syncytia formation, although no infectivity was demonstrated when the treated
virus was added to HEL (Table I). When the concentrated MPMV was diluted
ten-fold with growth medium or when unconcentrated MPMV was used for the
inoculum, KG cell syncytia formation was no longer detected even after several
transfers, although a chronic MPMV infection was established.
Infective titer of MPMVassayed on HEL. The end point dilution of the
culture supernatant of GMMT which still contained infectious virus was 10-4 •
It was not until after the second transfer of the MPMV-infected HEL that they
showed syncytia formation by cocultivation with KG cells. From the third
transfer of the infected HEL, the number and the size of syncytia increased,
although no syncytium was observed in mixed culture of HEL infected with 10-5
dilution of MPMV and KG cells. This indicated that the infectivity titer of the
MPMV was 104 syncytia forming units/0.2 m!.
Resistance of syncytia formation of MPMV-infected KC cells. KG cells showed
extensive syncytia formation when they were inoculated with concentrated
MPMV or cocultivated with MPMV-producing cells, however, MPMV-pro-
ducing KG cells were refractory to syncytia formation under the same conditions.
DISCUSSION
Both 40-fold concentrated live MPMV and virus killed by p-propiolactone
induced extensive KG cell syncytia formation within an hour. The infective titer
of MPMV in the culture supernatant of GMMT was 104 syncytia forming
units/O.2m1• Therefore 4D-fold concentrated virus solution contained about 106
syncytia forming units/m!. KG cells inoculated with diluted or unconcentrated
MPMV induced no KG syncytia formation even after several transfers, although
they produced progeny MPMV. This indicates that KG cell fusion is only fusion
from without caused by inoculated virus and there is no fusion from within
caused by progeny virus as with XG cell fusion by MuLV (6). As the anti-
MPMV serum neutralized the syncytia forming ability of MPMV, it is most
likely that viral spikes (glycoproteins) play an important role in syncytia forma-
tion as with paramyxoviruses (10, 11) and murine leukemia virus (6). The ab-
sence of syncytia formation when pelleted MPMV was used for the inoculum
suggested that this procedure removed viral spikes. The susceptibility of the
HEL used for ass3.Y cells for viral titration was too low for the development of
clear plaque assay for MPMV as in the XG plaque test for MuLV (12). Though
Rand et al. (4) described quantitative KG plaque assay for MPMV using RD and
WI-38 cells as assay cells, it was necessary in our experiments to transfer the
MPMV-infected HEL at least twice to obtain syncytia formation. Therefore,
it was impossible to know the exact infective titer of MPMV, though the end
point dilution titer could be determined.
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It has been reported that MPMV-producing KC cells (3) and RD 114 feline
virus-producing KC cells (13) resisted syncytia formation by respective viruses.
Our results confirmed this finding. Similary MuLV-producing XC cells resisted
cell fusion (6, 14) which was probably due to interference with inoculum virus
by the MuLV from XC cells (6) which is known as the "virus interference
phenomenon" in virology.
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